This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dove, A. CD18 trials disappoint again. Nat Biotechnol 18, 817–818 (2000). https://doi.org/10.1038/78412
Issue Date:
DOI: https://doi.org/10.1038/78412
This article is cited by
-
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
Nature Communications (2020)
-
The inflammatory response in myocardial injury, repair, and remodelling
Nature Reviews Cardiology (2014)
-
New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia
Immunologic Research (2013)
-
P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo
Purinergic Signalling (2013)
-
Retroinfusion of NFκB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs
Gene Therapy (2002)